Ph.D. in Life Sciences completed by 30 years of scientific and management roles in life tech organizations with 20 years in managing the Assay R&D for a global diagnostic industry providing IVD tests, Instruments and Systems in the domain of Infectious diseases.
As the Founder and Senior consultant at PSRD Consult, I provide my experience to Biotech, LifeTech and Diagnostic industries. My passport: I have done it many times from start to finish !
My in-depth practice of the overall R&D processes involved in new product development (NPD: Research & Innovation, feasibility studies, product and test development, product and test optimization) and Introduction (NPI: scale-up / ramp-up, V&V studies and design transfer to manufacturing) help my clients building efficient and best in class R&D processes for regulated environment.
Company Details
- Employees
- 1
- Founded
- -
- Address
- Massy, Ile De France 91300, Fr
- Industry
- Business Consulting And Services
- NAICS
-
Management, Scientific, and Technical Consulting ServicesManagement Consulting ServicesOther Scientific and Technical Consulting ServicesOther Management Consulting Services
- Keywords
- infectious Diseases, Virology, Bacteriology, Microbiology, Immuno-Assays, Point of care, Antibiotic resistance and culture media, Digital Biology, Portfolio prioritization, R&D budget (Opex, Capex) planing and monitoring, Multidisciplinary teams, Remote management, Training & Development plan (KSM), R&D KPIs, Agile & Lean R&D, Project Management and Review (timeline, cost, quality), Leadership, Adpatability, Critical thinking and problem solving, Accountable, Transparency & Dedication.
- HQ
- MASSY, Ile de France
- Competitors
Psrd Consult Questions
Psrd Consult's LinkedIn profile is https://fr.linkedin.com/company/psrdconsult
Psrd Consult has
1 employees.
View email and phone details for 1
employees at Psrd Consult.
Psrd Consult's industry is
Business Consulting and Services
Psrd Consult's categories are Business Consulting and Services
Psrd Consult's founding year is 2024
